Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
BMY | BRISTOL MYERS SQUIBB CO | United States | $98.80B | 2,022,193,411 | 76.46% | 0.36% | Net Selling | Net Selling |
JNJ | JOHNSON & JOHNSON | United States | $357.77B | 2,408,767,228 | 69.52% | 0.19% | Net Selling | Net Selling |
GILD | GILEAD SCIENCES INC | United States | $83.57B | 1,245,774,616 | 83.54% | 1.09% | Net Selling | Net Selling |
AZN | ASTRAZENECA PLC | United Kingdom | $220.74B | 1,550,162,626 | 31.49% | 0.00% | ||
SNY | SANOFI | France | $117.90B | 1,264,799,969 | 19.51% | 0.00% | ||
GSK | GSK PLC | United Kingdom | $82.86B | 4,056,000,000 | 7.26% | 0.00% | ||
NVS | NOVARTIS AG | Switzerland | $200.67B | 2,040,400,000 | 6.93% | 0.00% | ||
BIIB | BIOGEN INC | United States | $29.41B | 145,596,895 | 87.72% | 2.11% | Net Selling | Net Selling |
PFE | PFIZER INC | United States | $148.34B | 5,646,778,425 | 68.45% | 0.27% | Net Selling | Net Selling |
LLY | ELI LILLY & CO | United States | $695.71B | 950,164,452 | 82.44% | 11.18% | Net Selling | Net Selling |
AMGN | AMGEN INC | United States | $146.31B | 535,918,901 | 76.49% | 1.01% | Net Selling | Net Selling |
MRK | MERCK & CO INC | United States | $321.65B | 2,532,643,872 | 76.17% | 0.19% | Net Buying | Net Selling |
ABBV | ABBVIE INC | United States | $296.41B | 1,766,473,359 | 70.16% | 0.15% | Net Selling | Net Selling |
GRFS | GRIFOLS SA | United States | $4.39B | 687,554,908 | 17.73% | 0.00% | ||
AMRN | AMARIN CORP PLC | Ireland | $360.98M | 410,671,800 | 22.86% | 15.41% | Net Selling | Net Selling |
OGN | ORGANON & CO | United States | $4.78B | 255,638,256 | 77.39% | 0.19% | Net Selling | Net Selling |
SCLX | SCILEX HOLDING CO | United States | $141.26M | 166,189,835 | 15.74% | 37.69% |